Platelets mediate the action of diethylcarbamazine on microfilariae.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 3808054)

Published in Nature on March 24, 1987

Authors

J Y Cesbron, A Capron, B B Vargaftig, M Lagarde, J Pincemail, P Braquet, H Taelman, M Joseph

Articles by these authors

STUDIES IN THE POTASSIUM METABOLISM OF THE ANIMAL BODY BY MEANS OF ITS ARTIFICIAL RADIOACTIVE ISOTOPE. Science (1938) 17.27

Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med (1992) 5.29

Perspectives in platelet-activating factor research. Pharmacol Rev (1987) 5.27

Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today (1991) 3.79

Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2. Nat New Biol (1973) 3.41

p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell (1998) 3.27

Release of vasoactive substances from guinea-pig lungs by slow-reacting substance c and arachidonic acid. Its blockade by nonsteroid anti-inflammatory agents. Pharmacology (1971) 3.12

Treatment of hepatic hydatid disease with mebedazole: preliminary results in four cases. Br Med J (1977) 3.10

Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur J Pharmacol (1980) 2.90

[Immunoenzymologic diagnosis of parasitic diseases. II. Quantitative immunoenzymology]. Lille Med (1976) 2.74

Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg (1991) 2.62

Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet (1984) 2.43

Selective inhibition by mepacrine of the release of "rabbit aorta contracting substance" evoked by the administration of bradykinin. J Pharm Pharmacol (1972) 2.37

The role of platelet-activating factor in platelet aggregation. Nature (1979) 2.37

Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol (1992) 2.33

Background and present status of research on platelet-activating factor (PAF-acether). Ann N Y Acad Sci (1981) 2.22

Specific IgE antibodies in immune adherence of normal macrophages to Schistosoma mansoni schistosomules. Nature (1975) 2.19

Policy interventions that attract nurses to rural areas: a multicountry discrete choice experiment. Bull World Health Organ (2010) 2.17

Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol (1983) 2.17

Comparison of community based service with hospital based service for people with acute, severe psychiatric illness. BMJ (1993) 2.14

A new function for platelets: IgE-dependent killing of schistosomes. Nature (1983) 2.11

Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03

Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med (1994) 2.01

The liver to abdominal area ratio (LAAR): a novel imaging score for prognostication in cirrhosis. Aliment Pharmacol Ther (2013) 1.98

Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA (1987) 1.98

High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature (1994) 1.95

Suppression of asthma-like responses in different mouse strains by oral tolerance. Am J Respir Cell Mol Biol (2001) 1.95

Ligand binding was acquired during evolution of nuclear receptors. Proc Natl Acad Sci U S A (1997) 1.94

Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science (2001) 1.93

Requirement for gammadelta T cells in allergic airway inflammation. Science (1998) 1.93

Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest (1991) 1.91

Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J (2000) 1.89

Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med (1992) 1.88

Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension. Am Rev Respir Dis (1987) 1.87

Role of IgE receptors in effector function of human eosinophils. J Immunol (1984) 1.87

Heterosexual transmission of HIV. AIDS (1987) 1.84

Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med (2001) 1.79

Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. Am Rev Respir Dis (1988) 1.77

Using a claims database to investigate drug-induced Stevens-Johnson syndrome. Stat Med (1991) 1.77

Molecular crosstalk in host-parasite relationships: schistosome- and leech-host interactions. Parasitol Today (2000) 1.73

Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii. Proc Natl Acad Sci U S A (1989) 1.73

IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet (1988) 1.70

Acquired immunodeficiency syndrome in African patients. N Engl J Med (1984) 1.70

Serodiagnosis of toxoplasma infection using a purified parasite protein (P30). Clin Exp Immunol (1985) 1.64

Fc receptors for IgE on human and rat eosinophils. J Immunol (1981) 1.63

Evidence for IgE-dependent cytotoxicity by rat eosinophils. J Immunol (1981) 1.61

The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther (2007) 1.60

Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins. Infect Immun (1994) 1.50

The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. Gastroenterology (1996) 1.49

Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest (1995) 1.49

Murine models of asthma. Eur Respir J (2003) 1.49

Molecular cloning of a protective antigen of schistosomes. Nature (1987) 1.49

Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interfering with the NF-kappaB pathway. Eur J Immunol (1999) 1.49

Interaction between IgE complexes and macrophages in the rat: a new mechanism of macrophage activation. Eur J Immunol (1977) 1.48

Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J Bacteriol (1995) 1.48

Quantitative determination of specific IgE antibodies to Echinococcus granulosus and IgE levels in sera from patients with hydatid disease. Immunology (1975) 1.47

Effect of oral antioxidant supplementation on blood antioxidant status in trained thoroughbred horses. Vet J (2005) 1.47

Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol (1991) 1.46

Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. J Immunol (1987) 1.46

[Antigenic structure of helminthes. Immunological aspects of the host-parasite relationship]. Pathol Biol (1968) 1.45

Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)- octadecatrienoic acids from alpha-linolenic acid. J Biol Chem (1995) 1.45

Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. J Clin Invest (1983) 1.44

Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc Natl Acad Sci U S A (1995) 1.43

Role of free radicals and platelet-activating factor in the genesis of intestinal motor disturbances induced by Escherichia coli endotoxins in rats. Gastroenterology (1991) 1.43

Role of platelets in aspirin-sensitive bronchoconstriction in the guinea-pig; interactions with salicylic acid. Br J Pharmacol (1978) 1.43

Regulation of IgE production from human mononuclear cells by beta 2-adrenoceptor agonists. Clin Exp Allergy (1995) 1.42

The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene. Br J Pharmacol (1984) 1.42

An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in rats. Agents Actions (1989) 1.42

Enzyme release and superoxide anion production by human alveolar macrophages stimulated with immunoglobulin E. Clin Exp Immunol (1980) 1.42

Receptor for IgG(Fc) and human beta2-microglobulin on S. mansoni schistosomula. Nature (1979) 1.41

Preservation of cortical microcirculation after kidney ischemia-reperfusion: value of an iron chelator. Ann Vasc Surg (1994) 1.40

Efficacy of icatibant treatment in patients with hereditary angio-oedema type I resistant to treatment with C1 inhibitor concentrate. Br J Dermatol (2011) 1.40

Schistosomiasis co-infection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria. Parasite Immunol (2005) 1.40

A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis. J Immunol (1987) 1.39

Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. J Immunol (1989) 1.39

Fibronectin receptors on Trypanosoma cruzi trypomastigotes and their biological function. Nature (1984) 1.38

CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-gamma and accessory cells. Eur J Immunol (1993) 1.36

[Immunologic diagnosis of human echinococcosis. (Personal report apropos of 400 cases)]. Pathol Biol (Paris) (1970) 1.36

Cytophilic binding of IgE to the macrophage. II. Immunologic release of lysosomal enzyme from macrophages by IgE and anti-IgE in the rat: a new mechanism of macrophage activation. Cell Immunol (1979) 1.36

Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol (1993) 1.35

Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity. Clin Exp Immunol (1989) 1.35

Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes. Immunology (1993) 1.35

Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-alpha formation and neutrophil sequestration into the murine lungs. J Immunol (1998) 1.33

Eosinophil-dependent cytotoxicity in rat schistosomiasis. Involvement of IgG2a antibody and role of mast cells. Eur J Immunol (1978) 1.33

The receptor for IgE on blood platelets. Eur J Immunol (1986) 1.32

Toxoplasma gondii: characterization and localization of antigens secreted from tachyzoites. Exp Parasitol (1990) 1.32

IgA antibodies to a protective antigen in human Schistosomiasis mansoni. J Immunol (1993) 1.30

Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins Leukot Med (1984) 1.30

Common cis-acting elements critical for the expression of several genes of Toxoplasma gondii. Mol Microbiol (1996) 1.30